Leader of Innovative Molecular Diagnostics
In the 21st century ‘post-genome era’, major concern of life sciences is how to correctly use information contained in gene sequences in order to contribute to human health and welfare.
MGMED has developed and commercialized molecular diagnostic techniques to diagnose genetic diseases occurring at all stages of human life.
MGMED has exclusively produced microarray based on the genes obtained from the Korean Genome Project. For instance, BAC chip microarray can quickly and accurately determine numerical and structural abnormalities of chromosomes.
BAC chip can be further utilized for detecting chromosomal abnormalities in embryos for increasing success rate of in vitro fertilization (P-chip), checking health of fetus (M-chip, N-chip) and diagnosing chromosomal abnormalities in children and adults who have health problems (G-Chip). BAC CHIP also can detect chromosomal abnormalities in cancer cells (C-chip) and check chromosomal abnormalities in stem cells (S-chip).
In addition, MGMED makes our effort to develop reagents for diagnostic tools such as PCR kits for cervical cancer, sexually transmitted infections and other diseases. With endless efforts in research with honest enterprise sprit, MGMED will become a leading company in molecular diagnostics.